Tag Archives: government

CFSAC Profile: Dr. Gary Kaplan

The CFS Advisory Committee announced via its listserv on October 23, 2013 that Dr. Gary Kaplan has been appointed to the Committee. Kaplan brings an interesting point of view to the Committee, but advocates have reason to be concerned about … Continue reading

Posted in Advocacy | Tagged , , , , , , , , | 24 Comments

Don’t Lose Sight of CFSAC

The IOM controversy and the government shut down have been distracting, but CFS Advisory Committee deadlines are fast approaching. The CFSAC meeting is just three weeks away – November 12-13th – which means that public comment will be due soon, … Continue reading

Posted in Advocacy | Tagged , , , , , , | 16 Comments

Exhibit A

I’ve been very critical of HHS and how they have handled communications and engagement with the ME/CFS patient community, and the fiasco surrounding the Institute of Medicine study is a sinkhole of terrible engagement. But if HHS and/or the IOM … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , | 8 Comments

Which Paddle?

The IOM study is moving forward, and fast. I can confirm through multiple sources that the IOM has reached out to multiple ME/CFS organizations for nominations to the clinical case definition committee. Those nominations are due today. I can also … Continue reading

Posted in Advocacy | Tagged , , , , , | 45 Comments

Convergence

In the last two weeks, position statements on the IOM and ME/CFS case definitions have been outnumbered only by rumors and allegations. I’ve had trouble keeping up and I am immersed in this issue. I can’t imagine how challenging it … Continue reading

Posted in Advocacy | Tagged , , , , , , , | 45 Comments

Training Wheels

When the news about the IOM contract first broke on August 27th, I was at my training for FDA Patient Representatives. Here is my much delayed write-up of that training. Every year, the FDA Patient Representative Program holds an in-person … Continue reading

Posted in Advocacy | Tagged , , , , , , | 18 Comments

The Statement of Work

I have obtained a copy of the Statement of Work (SOW) for the Institute of Medicine study on clinical diagnostic criteria for ME/CFS. I am making that document available to you in its entirety through this link. I am also … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , | 52 Comments

Trust

Can you trust someone if you think they don’t respect you? There is an abundance of mistrust and disrespect among all participants in the ME/CFS landscape. I think it’s important to talk about because these attitudes have a significant impact … Continue reading

Posted in Commentary | Tagged , , , , , , , | 31 Comments

The Experts

Developments came fast and furious last night. First, the CFIDS Association announced that it would not oppose the IOM contract, but would actively call for the IOM to choose a panel that matches the CFS Advisory Committee recommendation from October … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , | 31 Comments

Contract Signed

This message was sent out via the CFS Advisory Committee listserv this evening: We are pleased to announce that the Institute of Medicine (IOM) will begin conducting a study on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome this month.  This … Continue reading

Posted in Advocacy | Tagged , , , , , | 7 Comments